Delivery Order SPE2DB22D3004-SPE2DB25FNF10

Award Date 10/15/24
Potential Completion Date 11/5/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract provides for the delivery of 801 mg Esbriet tablets over a period ending on April 17, 2024, with a ceiling value of $3,311.50. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Esbriet 801 mg tablets. The contract, valued at $3,311.50, is a firm fixed-price delivery order with a completion date of November 27, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Esbriet 801 mg tablets. The total ceiling value of the contract is $3,311.50, and the ultimate completion date is October 11, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor responsible for providing these...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,311.50 firm fixed-price contract is for the delivery of Esbriet 267 mg capsules, a specialty medication. The contract has an ultimate completion date of December 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a potential value of $9,934.50 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp will provide Esbriet 801 mg tablets to support military treatment programs and facilities. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $6,623.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Esbriet 801 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential total value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract, valued at $3,311.50, is for the delivery of 4565220507 - Esbriet 801 mg tablet in quantities of 90s. The contract has an ultimate completion date of August 12, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,311.50 delivery order is for the supply of Esbriet 801 mg tablets. The contract has an ultimate completion date of November 7, 2024 and is a firm fixed-price delivery order. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,425.95 and covers the delivery of Esbriet 801 mg tablets. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Esbriet 267 mg tablets, a pharmaceutical product, with a ceiling value of $3,425.95 and a period of performance through June 25, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FNF10
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Esbriet 801 mg tablets. The contract has a firm-fixed price of $3,311.50 and a completion date of November 5, 2024. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for the provision of a wide range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation.

Generated 1/14/25, 9:06 AM